Rani Therapeutics Statistics
NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8121-0.0167 (-2.01%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Rani Therapeutics by the numbers
Rani Therapeutics has a market capitalization of $114.1 million based on 115.42M shares outstanding. With trailing EPS of $-0.15, Rani Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 18.8% below its 200-day average.
Average daily trading volume is 752.29K shares, or about $610,936 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RANI valuation vs. peer median
| Metric | RANI | Peer median | Difference |
|---|---|---|---|
| Market cap | $114.12M | $114.84M | -1% |
| Avg. volume | 752.29K | 460.29K | +63% |
Peer median across 8 companies: COYA, UNCY, GNLX, PMVP, INO, QUCY, AARD, VTVT.
Valuation
- Market cap
- $114.12M
- EPS (TTM)
- $-0.15
- Shares outstanding
- 115.42M
Price and trading
- Previous close
- 0.8288
- Open
- 0.8128
- Day range
- 0.79 – 0.8369
- 52-week range
- 0.445 – 3.87
- 52-week change
- +62.42%
- 50-day moving average
- 0.8197
- Beta
- —
- Volume
- 232.17K
- Average volume
- 752.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 114.12M
- Forward Pe
- -4.27
- Eps
- -0.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.87
- Week52 Low
- 0.45
- Avg Volume
- 752.29K
- Shares Outstanding
- 115.42M
- Ma50
- 0.82
- Ma200
- 1.00
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -79.02%
- Pct From52w Low
- 82.49%